Such findings led scientists to label AOD-9604 as the worlds first drug with a metabolic mechanism of action for obesity meaning it works by accelerating fat metabolism rather than suppressing appetite
Standard dosing ranges from 0.25 to 0.5 mg daily, while micro-dosing protocols typically use 0.1 to 0.15 mg injected subcutaneously once or twice daily
Sikiric P, Gojkovic S, Krezic I, Smoday IM, Kalogjera L, Zizek H, Oroz K, Vranes H, Vukovic V, Labidi M, Strbe S, Baketic Oreskovic L, Sever M, Tepes M, Knezevic M, Barisic I, Blagaic V, Vlainic J, Dobric I, Staresinic M, Skrtic A, Jurjevic I, Boban Blagaic A, Seiwerth S
& Karamata, D
Wir begleiten Sie strukturiert, praxisnah, lsungsorientiert